LungSEQ Concurrent Panel, without PD‑L1
Also known as: Lung Cancer, FISH, c-MET, Next Generation Sequencing, NSCLC
Use
This test is intended to be used for the mutational profiling of tumors from patients with non‑small‑cell lung cancer (NSCLC) in order to help prioritize and direct treatment. It may be useful for patients who have become refractory to prior therapies and are searching for investigational targeted therapies offered in clinical trials, or for newly diagnosed patients who would like to know their mutational profile to inform treatment options with approved targeted therapies or for the identification of potential future clinical trials or future approvals of targeted therapies.
Special Instructions
Not provided.
Limitations
Not provided.
Methodology
NGS (Targeted)
Biomarkers
LOINC Codes
- 51968‑6
- 100019‑9
- 42777‑3
- 58483‑9
- 21665‑5
- 42783‑1
- 21702‑6
- 60495‑9
- 21719‑0
- 60033‑9
- 47969‑1
Result Turnaround Time
8-10 days
Related Documents
For more information, please review the documents below
Specimen
Tissue (FFPE)
Volume
Not provided
Minimum Volume
Not provided
Container
Paraffin‑embedded tissue slides, or FFPE tissue with circled H&E slide
Collection Instructions
Submit paraffin‑embedded tissue accompanied by a circled H&E slide indicating the area to be examined collected in a sterile biohazard plastic bag, or 19 FFPE tissue slides and H&E slide collected in a slide holder
Causes for Rejection
Decalcified specimens not acceptable; specimen should contain a minimum of 10 percent tumor nuclei; all specimens must be accompanied with pathology report
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | Preferred |
| Refrigerated | Acceptable |
| Frozen | Unacceptable |